z-logo
open-access-imgOpen Access
Molecular Docking Studies of Bioactive Compounds from Solenostemma Argel Leaf Extract as Potential Inhibitor for BCL-2 Antiapoptotic Proteins
Author(s) -
Mehad Mustafa Adam Khamiss; Khamiss,
Prakash C. Choudhary
Publication year - 2020
Publication title -
international journal of innovative science and research technology
Language(s) - English
Resource type - Journals
ISSN - 2456-2165
DOI - 10.38124/ijisrt20sep781
Subject(s) - docking (animal) , apoptosis , chemistry , pharmacology , computational biology , traditional medicine , biochemistry , biology , medicine , nursing
This article deals with anticancer studies of phytochemicals identified from Solenostemma Argel leaf extract using GC-MS analysis and molecular docking studies. B cell lymphoma-2 (BCL-2) agonists are useful for regulating apoptosis which is essential for several cancers. The aim of the present study is to investigate the BCl-2 agonist property of phytochemicals from the extract of S. Argel using an Insilco approach. The docking on human BCL-2 protein was determined by GOLD 3.0.1 software. It is concluded from the studies that compound suggested by GCMS at RT 17.1 minute is 4,5,7-trihydroxy isoflavone showed best result with highest fitness index

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here